Literature DB >> 21036776

Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.

Savio P D'Souza1, Mamas A Mamas, Douglas G Fraser, Farzin Fath-Ordoubadi.   

Abstract

AIMS: Prompt coronary reperfusion following acute ST-segment elevation myocardial infarction is pivotal to survival. Primary angioplasty is the gold standard in restoring reperfusion, but thrombolysis needs consideration when optimal call to balloon time is not feasible. Following lysis and with evolving pharmacoinvasive therapies, the advantage of routine, early percutaneous coronary intervention (PCI) over standard ischaemia-guided PCI remains debatable. We meta-analysed studies comparing these two interventional strategies. METHODS AND
RESULTS: A MEDLINE search for randomized control studies was performed using the search terms 'coronary, thrombolysis, early or immediate stenting, and acute ST-elevation myocardial infarction'. Further, relevant studies were identified from global cardiovascular scientific sessions/congresses. Two interventional strategies were studied in 3195 patients in eight trials and meta-analysed using a random effects model. The combined endpoint of 30-day mortality, re-infarction, and ischaemia was reached in 106/1487 (7.3%) patients in the routine early PCI group and in 199/1470 (13.5%) patients in the ischaemia-guided PCI group following lysis with odds ratio (OR) 0.47 [95% confidence interval (CI), 0.32-0.68, P < 0.0001] favouring routine early PCI, driven by significant reduction in both re-infarction OR 0.62 (95% CI, 0.42-0.90, P < 0.011) and ischaemia OR 0.21 (95% CI, 0.10-0.47, P < 0.001). Thirty-day mortality or major bleeding rates between strategies were not significantly different.
CONCLUSION: Where primary PCI is not feasible, our meta-analysis favours routine early PCI within 24 h of thrombolysis for acute ST-elevation myocardial infarction-a strategy that is safe and a time-target that is easily achievable. Early PCI is associated with reduced recurrence of ischaemia and re-infarction, but at no increased risk of major haemorrhage.

Entities:  

Mesh:

Year:  2010        PMID: 21036776     DOI: 10.1093/eurheartj/ehq398

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

1.  A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India: The Tamil Nadu-ST-Segment Elevation Myocardial Infarction Program.

Authors:  Thomas Alexander; Ajit S Mullasari; George Joseph; Kumaresan Kannan; Ganesh Veerasekar; Suma M Victor; Colby Ayers; Viji Samuel Thomson; Vijayakumar Subban; Justin Paul Gnanaraj; Jagat Narula; Dharam J Kumbhani; Brahmajee K Nallamothu
Journal:  JAMA Cardiol       Date:  2017-05-01       Impact factor: 14.676

Review 2.  Early reperfusion strategy for acute myocardial infarction: a need for clinical implementation.

Authors:  Yan Zhang; Yong Huo
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

3.  Pharmacoinvasive therapy for ST elevation myocardial infarction in China: a pilot study.

Authors:  Ling-hong Shen; Fang Wan; Long Shen; Song Ding; Xin-rong Gong; Zhi-qing Qiao; Yong-ping Du; Wei Song; Jie-yan Shen; Shu-xuan Jin; Jun Pu; Tian-bao Yao; Li-sheng Jiang; Wei-zhen Li; Guo-wei Zhou; Shao-wen Liu; Ya-ling Han; Ben He
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

4.  [Preclinical fibrinolysis in patients with ST-segment elevation myocardial infarction in a rural region].

Authors:  T Viergutz; J Grüttner; T Walter; C Weiss; B Haaff; G Pollach; C Madler; T Luiz
Journal:  Anaesthesist       Date:  2016-08-08       Impact factor: 1.041

5.  Is There Still a Role for Fibrinolysis in ST-Elevation Myocardial Infarction?

Authors:  C El Khoury; F Sibellas; E Bonnefoy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-02

Review 6.  Percutaneous Coronary Intervention after Fibrinolysis for ST-Segment Elevation Myocardial Infarction Patients: An Updated Systematic Review and Meta-Analysis.

Authors:  Feng Liu; Qinglong Guo; Guoqiang Xie; Han Zhang; Yaxi Wu; Lixia Yang
Journal:  PLoS One       Date:  2015-11-02       Impact factor: 3.240

7.  The prognostic utility of GRACE risk score in predictive cardiovascular event rate in STEMI patients with successful fibrinolysis and delay intervention in non PCI-capable hospital: a retrospective cohort study.

Authors:  Yotsawee Chotechuang; Arintaya Phrommintikul; Roungtiva Muenpa; Jayanton Patumanond; Tuanchai Chaichuen; Srun Kuanprasert; Noparat Thanachikun; Thanawat Benjanuwatra; Apichard Sukonthasarn
Journal:  BMC Cardiovasc Disord       Date:  2016-11-08       Impact factor: 2.298

8.  Observational study comparing pharmacoinvasive strategy with primary percutaneous coronary intervention in patients presenting with ST elevation myocardial infarction to a tertiary care centre in India.

Authors:  A G Alex; A Lahiri; T Geevar; O K George
Journal:  J Postgrad Med       Date:  2018 Apr-Jun       Impact factor: 1.476

Review 9.  Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction.

Authors:  Mun K Hong
Journal:  Scientifica (Cairo)       Date:  2012-09-16

Review 10.  Is exercise-based cardiac rehabilitation effective? A systematic review and meta-analysis to re-examine the evidence.

Authors:  Richard Powell; Gordon McGregor; Stuart Ennis; Peter K Kimani; Martin Underwood
Journal:  BMJ Open       Date:  2018-03-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.